Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03095248
Title Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors (SEL-TH-1601)
Acronym SEL-TH-1601
Recruitment Suspended
Gender both
Phase Phase II
Variant Requirements No
Sponsors Children's Hospital Medical Center, Cincinnati
Age Groups: child | adult
Covered Countries USA

Facility Status City State Zip Country Details
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229 United States Details
*Shaded cells indicate that there was no data available from for the field